PAVM
PAVmed Inc.
NASDAQ · Healthcare · Medical - Devices · US
$3.96
−0.25%Sep 10, 2026, 10:29 UTC
PAVmed Inc. signed a sales agreement with A.G.P./Alliance Global Partners to sell up to $9,400,000 of its common stock in an at-the-market offering.
Aug 14, 2026, 17:37 UTC
PAVmed Inc. held its Q2 2026 earnings call on August 14, 2026, to discuss financial results.
Source:Jun 24, 2026, 00:00 UTC
PAVmed Inc. elected Ronald M. Sparks and Timothy Baxter as Class A directors effective June 24, 2026.